Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68b02393f5434d48fca8b8ca",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 50",
"description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.",
"price": 375.0,
"discountamount": 112.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2165,
"imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:38:27.036Z",
"updatedon": "2025-08-28T09:38:27.036Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 50 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6890aa548a215c65672372e1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "EMPATECH LINA 25/5",
"description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.",
"price": 345.0,
"discountamount": 104.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2154,
"imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-04T12:40:52.619Z",
"updatedon": "2025-08-04T12:40:52.619Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Empagliflozin and Linagliptin Tablets",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and Linagliptin Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68822dd35b399ba6097ed11b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "SEIZMET G 0.5 FORTE",
"description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.",
"price": 125.0,
"discountamount": 38.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2151,
"imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-24T12:57:55.385Z",
"updatedon": "2025-07-24T12:57:55.385Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "glimepiride and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "681c5e9e5a26e4010ea42029",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ST-GLIPTIN M 100/ 1000",
"description": "ST-GLIPTIN M 100/1000 is an advanced oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus. This powerful combination of Sitagliptin (100 mg) and Metformin Hydrochloride (1000 mg) offers dual action in controlling elevated blood glucose levels, especially in patients who do not respond adequately to metformin or sitagliptin alone. It is intended for adults and is generally used in conjunction with diet and exercise to enhance glycemic control.\n\nKey Ingredients\nSitagliptin (100 mg)\nSitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.\n\nMetformin Hydrochloride (1000 mg)\nMetformin belongs to the biguanide class of antidiabetics. It works by reducing the amount of sugar produced by the liver and improves the body’s sensitivity to insulin, facilitating better glucose utilization.\n\nKey Benefits\nHelps reduce both fasting and postprandial (after-meal) blood glucose levels effectively\nImproves overall glycemic control in patients with Type 2 diabetes\nCombines two different mechanisms of action for better diabetes management\nMinimizes the risk of hypoglycemia compared to other antidiabetic therapies\nMay support weight neutrality or slight weight loss in diabetic individuals\n\nHow Does It Work?\nST-GLIPTIN M 100/1000 works through a synergistic mechanism by combining two effective antidiabetic agents:\n\nSitagliptin enhances the levels of incretin hormones, which help the pancreas produce more insulin and reduce the secretion of glucagon, especially when blood sugar is high.\nMetformin reduces hepatic glucose production and increases insulin sensitivity, which helps the body use glucose more efficiently.\nTogether, these agents provide comprehensive blood sugar control by addressing multiple physiological pathways involved in glucose metabolism.\n\nDirections for Use\nTake ST-GLIPTIN M 100/1000 exactly as prescribed by your physician.\nIt is typically taken once or twice daily with meals to reduce gastrointestinal side effects and optimize absorption.\nSwallow the tablet whole with water. Do not crush or chew the tablet.\nMaintain a balanced diet and follow an active lifestyle for best results.\nRegular blood sugar monitoring is essential to assess effectiveness and make any necessary dosage adjustments.\n\nSide Effects\nCommon side effects may include nausea, diarrhea, stomach upset, or headache.\nSome individuals may experience respiratory tract infections, sore throat, or a runny nose.\nLactic acidosis is a rare but serious side effect associated with high-dose metformin—seek immediate medical attention if symptoms like unusual fatigue, muscle pain, difficulty breathing, or abdominal discomfort occur.\nAllergic reactions such as rash, itching, or swelling are uncommon but possible.\nAlways inform your doctor of any persistent or bothersome side effects for timely intervention.",
"price": 225.0,
"discountamount": 68.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"1001000 works",
"100 1000stgliptin",
"work stgliptin",
"balanced diet",
"tablet maintain",
"diabetic individuals",
"sitagliptin 100 mg",
"timely intervention",
"rash itching",
"medical attention",
"highdose metforminseek",
"assess effectiveness",
"active lifestyle",
"pancreas produce",
"synergistic mechanism",
"antidiabetic therapies",
"hypoglycemia compared",
"glycemic control",
"biguanide class",
"incretin hormones",
"respond adequately",
"powerful combination",
"insulin facilitating",
"sugar produced",
"side effect",
"bodys sensitivity",
"effective management",
"blood sugar",
"increases insulin sensitivity",
"regulate blood sugar",
"glucose metabolism directions",
"increasing insulin release",
"bothersome side effects",
"diabetes management minimizes",
"optimize absorption swallow",
"slight weight loss",
"support weight neutrality"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2107,
"imageuri": "https://productimages.withfloats.com/actual/681c5e9f5e6dd8f19a0309c3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/681c5e9f5e6dd8f19a0309c3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-08T07:34:54.516Z",
"updatedon": "2025-05-08T07:35:36.782Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/st-gliptin-m-100-1000/2107",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "sitagliptin and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin and Metformin hydrochloride tablets Uses in Hindi",
"sitagliptin and metformin hydrochloride tablets 50/1000 uses in hindi",
"sitagliptin and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "681c57a735606e4776e9d16e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ST-GLIPTIN M 100/ 500",
"description": "ST-GLIPTIN M 100/500 is an oral antidiabetic medication designed to help manage Type 2 Diabetes Mellitus effectively. It combines two powerful ingredients, sitagliptin and metformin hydrochloride, which work together to help control blood sugar levels in adults.\n\nKey Ingredients:\n\nSitagliptin (100 mg): A DPP-4 inhibitor that helps increase the levels of incretin hormones, thereby stimulating insulin release and reducing glucose production by the liver.\n\nMetformin Hydrochloride (500 mg): A biguanide that improves insulin sensitivity and reduces hepatic glucose production.\n\nKey Benefits:\n\nHelps maintain healthy blood glucose levels.\n\nEnhances insulin sensitivity in the body.\n\nLowers glucose production in the liver.\n\nReduces the risks associated with high blood sugar, like cardiovascular complications.\n\nHow Does It Work?\nSitagliptin works by inhibiting the DPP-4 enzyme, which prolongs the activity of incretin hormones. These hormones help regulate blood sugar levels by increasing insulin release from the pancreas and decreasing glucagon levels. Metformin acts primarily by reducing the amount of sugar the liver produces and increasing the body's response to insulin. Together, they help achieve better glycemic control.\n\nDirections for Use:\nTake ST-GLIPTIN M 100/500 as prescribed by your healthcare professional. It is usually taken with meals to reduce gastrointestinal side effects. Do not skip doses and avoid self-adjusting the medication without consulting your doctor.\n\nSide Effects:\nSome common side effects may include:\n\nNausea or vomiting\n\nDiarrhea\n\nStomach upset\n\nHeadache\n\nSerious side effects are rare but may include lactic acidosis, allergic reactions, or severe hypoglycemia. Consult your healthcare provider immediately if you experience unusual symptoms.",
"price": 195.0,
"discountamount": 59.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"100 500stgliptin",
"incretin hormones",
"avoid selfadjusting",
"skip doses",
"bodys response",
"liver produces",
"dpp4 enzyme",
"cardiovascular complications",
"liver reduces",
"helps increase",
"dpp4 inhibitor",
"metformin hydrochloride",
"healthcare professional",
"side effects",
"increasing insulin release",
"work sitagliptin works",
"high blood sugar",
"reducing glucose production",
"common side effects",
"doctor side effects",
"healthcare provider immediately",
"improves insulin sensitivity",
"stimulating insulin release",
"experience unusual symptoms",
"severe hypoglycemia consult",
"glycemic control directions",
"powerful ingredients sitagliptin"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2106,
"imageuri": "https://productimages.withfloats.com/actual/681c57a9d913fb8772192d78.png",
"tileimageuri": "https://productimages.withfloats.com/tile/681c57a9d913fb8772192d78.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-08T07:05:11.998Z",
"updatedon": "2025-05-08T07:05:11.998Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/st-gliptin-m-100-500/2106",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "sitagliptin and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68134d097702eb2332e5ccb0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "GLICLAGLAZE 40",
"description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.",
"price": 120.0,
"discountamount": 34.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"gliclaglaze 40",
"exercise plan",
"balanced diet",
"meals swallow",
"nephropathy suitable",
"gliclaglaze 40gliclaglaze 40",
"seizures occur",
"confusion fainting",
"severe hypoglycemia",
"medical attention",
"temporary seek",
"patients rare",
"lightheadedness nausea",
"track progress",
"regular schedule",
"daily preferably",
"healthcare provider",
"oxidative damage",
"hypoglycemia compared",
"glucosedependent manner",
"specific receptors",
"lifestyle measures",
"microvascular complications",
"secondgeneration sulfonylurea",
"uncontrolled diabetes",
"manage diabetes",
"specifically designed",
"chew maintain",
"glucose levels",
"cardiovascular protection",
"promoting insulin secretion",
"diabetic patients directions",
"older sulfonylureas additionally",
"medication works primarily",
"oral antidiabetic medication",
"stable glucose profile",
"insufficient helps maintain",
"vascular protection making",
"thrombocytopenia visual disturbances",
"antioxidant properties contribute",
"longterm glycemic control",
"pancreatic beta cells",
"lowers blood sugar",
"offering antioxidant properties"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2099,
"imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-01T10:29:29.141Z",
"updatedon": "2025-05-01T10:29:29.141Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Gliclazide 40 mg",
"category": "DIABETIC RANGE",
"tags": [
"Gliclazide 40 mg uses in Hindi",
"Gliclazide 40mg brands",
"Gliclazide 40 mg price",
"Gliclazide 40mg side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67c5887fcd301704c9b6528a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Repaglinide 0.5mg",
"description": "RAPIGLINIDE 0.5 contains Repaglinide 0.5 mg, a medication used in the treatment of Type 2 diabetes mellitus. It belongs to a class of drugs known as meglitinides, which help control blood sugar levels by stimulating insulin production from the pancreas. RAPIGLINIDE is commonly prescribed to individuals who are unable to maintain optimal blood glucose levels through diet and exercise alone. It can be used alone or in combination with other oral diabetes medications to help manage blood sugar levels effectively.\n\n \nKey Benefits:\n \n Effective Blood Sugar Control – Helps lower postprandial blood glucose levels, effectively managing blood sugar spikes after meals.\n Rapid Action – Starts working quickly, offering fast relief from elevated blood sugar levels.\n Flexible Dosing – Can be taken before meals, giving flexibility in meal planning and diabetes management.\n Helps Prevent Complications of Diabetes – By controlling blood sugar levels, it helps in reducing the risk of complications associated with diabetes, such as nerve damage, heart disease, and kidney issues.\n Used Alone or with Other Diabetes Medications – RAPIGLINIDE 0.5 can be combined with other oral diabetes drugs for better blood sugar management.\n\n \nHow Does It Work?\n \n\nRepaglinide 0.5 mg works by stimulating the beta cells in the pancreas to secrete insulin when blood sugar levels rise after meals. The medication acts quickly, allowing the body to use glucose more effectively and preventing high blood sugar spikes. Unlike other long-acting insulin medications, Repaglinide acts quickly but for a short duration, making it suitable for controlling blood sugar right after eating. It helps in maintaining optimal postprandial glucose levels, which is crucial for the management of Type 2 diabetes.\n\n \nDirections for Use:\n \n\nTake RAPIGLINIDE 0.5 exactly as prescribed by your doctor.\nThe typical dosage is 0.5 mg to 2 mg taken before meals, 2 to 3 times daily.\nSwallow the tablet whole with water.\nDo not take more than the prescribed dose, and never skip doses.\nIf you miss a dose, take it as soon as you remember before the next meal. If it's almost time for your next meal, skip the missed dose—do not double the dose.\n \nSide Effects:\n \n\nWhile RAPIGLINIDE 0.5 is generally well-tolerated, some people may experience:\n\nHypoglycemia (low blood sugar): Symptoms include dizziness, sweating, shaking, confusion, and headaches.\nNausea or diarrhea\nWeight gain (in some cases)\nHeadache or dizziness\nRash or itching (rare)\nAbdominal discomfort\nIf you experience any signs of severe hypoglycemia (such as confusion, blurred vision, or seizures), or severe allergic reactions (such as difficulty breathing, swelling of the face or throat), seek immediate medical attention.",
"price": 217.0,
"discountamount": 66.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"2 mg",
"05 mg",
"rapiglinide 05",
"meals 2",
"pancreas rapiglinide",
"repaglinide 05 mg",
"meal skip",
"prescribed dose",
"meal planning",
"commonly prescribed",
"medical attention",
"throat seek",
"dizziness rash",
"cases headache",
"headaches nausea",
"generally welltolerated",
"missed dosedo",
"skip doses",
"typical dosage",
"beta cells",
"kidney issues",
"repaglinide 05mgrapiglinide 05",
"severe hypoglycemia",
"secrete insulin",
"oral diabetes drugs",
"stimulating insulin production",
"meals giving flexibility",
"dose side effects",
"blood sugar management",
"oral diabetes medications",
"severe allergic reactions",
"difficulty breathing swelling",
"confusion blurred vision",
"diarrhea weight gain",
"controlling blood sugar",
"short duration making"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2063,
"imageuri": "https://productimages.withfloats.com/actual/67c588a2587befa5fb853a41.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67c588a2587befa5fb853a41.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-03T10:46:23.834Z",
"updatedon": "2025-03-03T10:46:56.222Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/repaglinide-0-5mg/2063",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "RAPIGLINIDE 0.5",
"category": "DIABETIC RANGE",
"tags": [
"Repaglinide 0.5 Mg Tablet Uses in Hindi",
"Repaglinide 0.5 mg tablet uses",
"Repaglinide 0.5 mg brand name",
"Repaglinide brand name",
"Repaglinide side effects 0.5 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67a35ad2c50c07ee3dcaceda",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg",
"description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.",
"price": 185.0,
"discountamount": 56.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"lower risk",
"nephrons reduces",
"reducing strain",
"weight management",
"diabetes management",
"chest pain",
"doctor immediately",
"lactic acidosis",
"rare cases",
"prolonged metformin",
"nausea diarrhea",
"experience mild",
"crush chew",
"glycemic control",
"mechanisms ensure",
"peripheral tissues",
"kidneys leading",
"diabetes treatments",
"hypoglycemia unlike",
"bodys response",
"heart disease",
"weight loss",
"medication aids",
"regular exercise",
"proper diet",
"biguanide therapy",
"sglt2 inhibition",
"complementary mechanisms",
"empagliflozin dehydration",
"excess glucose",
"eliminating excess glucose",
"work empagliflozin works",
"diabetic ketoacidosis consult",
"frequent urination due",
"moderate side effects",
"gliempaflozin met 125mg1000mg",
"results side effects",
"healthcare provider timing",
"insulin production directions",
"enhances insulin sensitivity"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2047,
"imageuri": "https://productimages.withfloats.com/actual/67a35b5ff147b76947dad0ce.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35b5ff147b76947dad0ce.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:34:26.615Z",
"updatedon": "2025-03-22T10:19:44.132Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-1000mg/2047",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ",
"category": "",
"tags": [
"empagliflozin 12.5 mg+metformin 500 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "674b0a7ee34075b8291b14f1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets",
"description": "Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.\n\n \nKey Benefits:\nEffective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.\nReduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.\nMinimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.\nImproves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.\nSustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.\nComprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.\nHow Does It Work?\nGlimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.\nVoglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.\nMetformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.\nTogether, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.\n\nDirections for Use:\nDosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.\nSwallow Whole: Do not crush or chew the tablet; it is designed for sustained release.\nTiming: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.\nFollow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.\nAlways consult your doctor before starting or adjusting your dosage.\n\nSide Effects:\nWhile Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nStomach discomfort or flatulence\nMild hypoglycemia (low blood sugar levels)\nRare but Serious Side Effects:\n\nSevere hypoglycemia\nLactic acidosis (from Metformin)\nAllergic reactions such as rash or itching\n\n",
"price": 153.0,
"discountamount": 46.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"prescribed dosage",
"ingredients address",
"glycemic control",
"targets fasting",
"generally welltolerated",
"glimiteris trio 0502500",
"optimal results",
"meals swallow",
"healthcare professional",
"holistic solution",
"multifaceted nature",
"cardiovascular issues",
"neuropathy retinopathy",
"insulin improving",
"bodys response",
"multiple pathways",
"synergistic combination",
"multifaceted approach",
"dosage side effects",
"delaying glucose absorption",
"postprandial blood glucose",
"metformin allergic reactions",
"diarrhea stomach discomfort",
"experience side effects",
"reduce gastrointestinal discomfort",
"work glimepiride stimulates",
"proven antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2016,
"imageuri": "https://productimages.withfloats.com/actual/674b0a80ec7bb8b7dcae8a8a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/674b0a80ec7bb8b7dcae8a8a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-11-30T12:52:14.799Z",
"updatedon": "2024-11-30T12:52:14.799Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-0-5-mg-voglibose-0-2-mg-metformin-hydrochloride-sr-500-mg-tablets/2016",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS TRIO 0.5/0.2/500 ",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}